Change and clinical significance of CD5L in trauma-associated-ALI/ARDS

Predictive value of elevated serum levels of CD5L in acute lung injury and acute respiratory distress syndrome following trauma

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000035131

Enrollment

Unknown

Registered

2020-08-01

Start date

2020-07-25

Completion date

Unknown

Last updated

2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

trauma

Interventions

trauma associated-ALI/ARDS group:none

isolated trauma group:none

Eligibility

Sex/Gender

All

Age

16 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 16-80 years; 2. Male or female; 3. Emergency department admissions (patients admitted within 24h after trauma); 4. Patient signs informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who were rehospitalized; 2. Patients had a history of chronic interstitial lung disease or were diagnosed with congestive heart failure; 3. Patients with cancer, pneumonia, liver fibrosis, atopic dermatitis autoimmune disease (such as, rheumatoid arthritis, systemic lupus erythematosus, psoriasis and psoriatic arthritis), skin disease, chronic apical periodontitis and diabetes mellitus; 4. Patients with mental illness; 5. Pregnant woman; 6. Patients who are unwilling to cooperate or have communication barriers.

Design outcomes

Primary

Measure	Time frame
CD5 antigen-like protein;	—

Countries

China

Contacts

Public ContactLuo Yan

The First Affiliated Hospital of Chongqing Medical University

LuoYan476534@126.com+86 13883143775

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026